Selvita S.A. (WSE:SLV)

Market Cap	565.35M -9.1%
Revenue (ttm)	359.93M +0.0%
Net Income	-3.65M
EPS	-0.21
Shares Out	18.36M
PE Ratio	n/a
Forward PE	22.77
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,996
Open	31.10
Previous Close	30.80
Day's Range	29.70 - 31.10
52-Week Range	26.50 - 49.40
Beta	0.12
Analysts	Buy
Price Target	49.15 (+63.29%)
Earnings Date	May 21, 2026

About Selvita

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libraries; structural biology, fragment-based drug discovery, protein production, modification, and characterization; vitro assays and model, mechanistic a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 691
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SLV